Where did you get those eyes and that brain?

Alzheimer's disease risk increases with maternal inheritance

2010-11-16

(Press-News.org) Philadelphia, PA, 15 November 2010 - A family history of Alzheimer's disease significantly increases the risk for developing this disorder, but a new study in Biological Psychiatry suggests that which of your parents has the disease is very important.

Alzheimer's is the most common form of dementia in late-life, affecting over 5 million elderly in the United States alone. In order to develop preventative treatments, it is necessary to identify those individuals who are at highest risk for developing Alzheimer's.

Although individuals with a parental history of Alzheimer's are at increased risk for developing the disease, the specific biological and genetic mechanisms accounting for this increased risk are not known.

An important consideration may be a phenomenon called genomic imprinting, where the pattern of the inherited disease differs based on whether the risk genes are inherited from the mother or the father. Imprinting is a type of epigenetic regulation, meaning that long lasting changes in gene function are produced through regulatory mechanisms rather than by altering the sequence of the DNA.

In this new study, researchers set out to evaluate Alzheimer's risk in healthy, cognitively normal individuals by measuring their cerebrospinal fluid proteins, which are known to be altered in Alzheimer's. They compared individuals with a maternal or paternal history of Alzheimer's to individuals with no family history.

Only individuals whose mothers had Alzheimer's showed altered levels of a protein called amyloid, a major hallmark of Alzheimer's pathology, as well as proteins involved with oxidative stress (i.e., free radicals, which are harmful to the brain as well as the rest of the body). In contrast, individuals whose fathers had Alzheimer's and those with no family history had protein levels within normal range.

"Our data indicate that adult children of mothers with Alzheimer's may be at increased risk for developing the disease," explained Dr. Lisa Mosconi, the first author on the study. "It is therefore extremely important to understand the genetic mechanisms involved in maternal transmission of Alzheimer's disease, which are currently unknown. Identifying a genetic predictor for the disease might lead to preventive treatments years before the onset of clinical symptoms."

Dr. John Krystal, Editor of Biological Psychiatry, added: "This study is very important because we are just beginning to understand the epigenetic control of particular genes. In theory, some day, one might develop a medication that reduces the risks associated with a maternal history of Alzheimer's disease."

The authors cautioned that additional follow-up research is now needed to test the usefulness of these protein measures for predictive purposes and to investigate potential susceptibility genes for Alzheimer's disease.

### Notes to Editors:

The article is "Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's" by Lisa Mosconi, Lidia Glodzik, Rachel Mistur, Pauline McHugh, Kenneth E. Rich, Elizabeth Javier, Schantel Williams, Elizabeth Pirraglia, Susan De Santi, Pankaj D. Mehta, Raymond Zinkowski, Kaj Blennow, Domenico Pratico, and Mony J. de Leon. Mosconi, Glodzik, Mistur, McHugh, Rich, Javier, Williams, Pirraglia, De Santi, and de Leon are affiliated with New York University School of Medicine, New York, New York. de Leon is also with Nathan Kline Institute, Orangeburg, New York. De Santi is also with Bayer HealthCare Pharmaceuticals Inc., Montville, New Jersey. Mehta is from the Institute for Basic Research, Staten Island, New York. Zinkowski is affiliated with Applied Neurosolutions, Vernon Hills, Illinois. Blennow is from University of Göteborg, Sahlgrenska University Hospital, Gothenburg, Sweden. Pratico is with Temple University School of Medicine, Philadelphia, Pennsylvania. The article appears in Biological Psychiatry, Volume 68, Issue 10 (November 15, 2010), published by Elsevier.

The authors' disclosures of financial and conflicts of interests are available in the article.

John H. Krystal, M.D. is Chairman of the Department of Psychiatry at the Yale University School of Medicine and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial and conflicts of interests are available at http://journals.elsevierhealth.com/webfiles/images/journals/bps/Biological-Psychiatry-Editorial-Disclosures-7-22-10.pdf.

Full text of the article mentioned above is available upon request. Contact Chris J. Pfister at c.pfister@elsevier.com to obtain a copy or to schedule an interview.

About Biological Psychiatry

This international rapid-publication journal is the official journal of the Society of Biological Psychiatry. It covers a broad range of topics in psychiatric neuroscience and therapeutics. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and treatment of major neuropsychiatric disorders. Full-length and Brief Reports of novel results, Commentaries, Case Studies of unusual significance, and Correspondence and Comments judged to be of high impact to the field are published, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Concise Reviews and Editorials that focus on topics of current research and interest are also published rapidly.

Biological Psychiatry (www.sobp.org/journal) is ranked 4th out of 117 Psychiatry titles and 13th out of 230 Neurosciences titles in the 2009 ISI Journal Citations Reports® published by Thomson Reuters. The 2009 Impact Factor score for Biological Psychiatry has increased to 8.926.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

ELSE PRESS RELEASES FROM THIS DATE:

Study: Teleworkers more satisfied than office-based employees

2010-11-16

Employees who telecommute the majority of the work week are more satisfied with their jobs compared to those working mostly in the office because working remotely alleviates more stress than it creates, according to a new study by a communication researcher at the University of Wisconsin-Milwaukee (UWM). The study, conducted by Kathryn Fonner, UWM assistant professor of communication, and Michael Roloff, a professor of communication studies at Northwestern University, compared the advantages and disadvantages of each work arrangement. A paper outlining the results appears ...

Prostate cancer treatment linked to higher rate of colon cancer, study finds

2010-11-16

ANN ARBOR, Mich. — Men treated with hormone-based therapy for prostate cancer faced a 30 percent to 40 percent higher risk of colorectal cancer, compared to patients who did not receive this treatment, according to a new study. The study looked at use of androgen deprivation therapy, a common type of treatment for prostate cancer that involves blocking the male hormone testosterone through either surgical removal of the testicles or a series of injections. It's been shown to benefit men with advanced cancers, but its benefit for less-advanced disease is unclear. Still, ...

Robo-op marks new world first for heart procedure

2010-11-16

The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester. It comes six months after Dr Andre Ng carried out the first ever remote catheter ablation procedure using the Amigo Robotic Catheter System. Dr Ng, is senior lecturer at the University of Leicester and consultant cardiologist and electrophysiologist at Glenfield Hospital. On Tuesday 16 November, Dr Ng will be carrying out another "world first" using the robotic arm in combination with advanced 3-dimensional mapping to fix ...

Happiness slides across Europe as speculation mounts on new UK government happiness index

2010-11-16

Emotional prosperity in Europe is falling, and this troubling fact needs to be faced by the European governments. That is the conclusion from a new research report from the University of Warwick which documents cross-country evidence on psychological health and mental well-being. The study, by Andrew Oswald, professor of behavioural science at Warwick Business School, draws together the latest statistical evidence from a range of social-science, science and medical journals. The study is to be published in the December issue of the British Journal of Industrial Relations. ...

Children's Hospital of Philadelphia collaborates in gene therapy success in an immune disorder

2010-11-16

A pediatric immunologist at The Children's Hospital of Philadelphia collaborated with European gene therapy researchers who achieved marked clinical improvements in two young children with Wiskott-Aldrich syndrome, a very rare but often severe immunodeficiency disorder. Jordan S. Orange, M.D., Ph.D., an expert in Wiskott-Aldrich syndrome (WAS), performed sophisticated cell imaging and analysis for the study, led by German researcher Christoph Klein, M.D., Ph.D., of Hannover Medical School. Orange was a senior co-author, and Children's Hospital was the only U.S. institution ...

Homeopathy consultations can benefit arthritis patients, say scientists

2010-11-16

New evidence that homeopathic consultations can reduce the symptoms of rheumatoid arthritis has been revealed by scientists from the University of Southampton. In a study published today in the journal Rheumatology, researchers found that arthritis patients significantly benefited when they received homeopathy alongside conventional treatment over a period of 6 months, but this improvement was due to homeopathy's consultation process and not its remedies. "Although previous trials have shown homeopathy may help patients with rheumatoid arthritis, this is the first ...

Palliative care for patients with dementia more available but still not adequate

2010-11-16

INDIANAPOLIS – A new national survey conducted by researchers from Indiana University and the Regenstrief Institute has found that while palliative care may be available for those with dementia, there are significant barriers to providing or receiving services to relieve the pain, eating difficulties and other symptoms associated with dementia. The survey findings are reported in the Nov. 2010 issue of the Journal of the American Geriatrics Society. "Although the general public and many physicians do not associate palliative or hospice care with dementia, dementia is ...

New test can screen all deafness genes simultaneously

2010-11-16

Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000. It means quicker answers for families anxious to determine treatment options ...

Synchrotron reveals human children outpaced Neanderthals by slowing down

2010-11-16

Human childhood is considerably longer than chimpanzees, our closest-living ape relatives. A multinational team of specialists, led by researchers from Harvard University, Max-Planck Institute for Evolutionary Anthropology (MPI-EVA) and the ESRF, applied cutting-edge synchrotron X-ray imaging to resolve microscopic growth in 10 young Neanderthal and Homo sapiens fossils. They found that despite some overlap, which is common in closely-related species, significant developmental differences exist. Modern humans are the slowest to the finish line, stretching out their maturation, ...

New standard proposed for supercomputing

2010-11-16

ALBUQUERQUE, N.M. — A new supercomputer rating system will be released by an international team led by Sandia National Laboratories at the Supercomputing Conference 2010 in New Orleans on Nov. 17. The rating system, Graph500, tests supercomputers for their skill in analyzing large, graph-based structures that link the huge numbers of data points present in biological, social and security problems, among other areas. "By creating this test, we hope to influence computer makers to build computers with the architecture to deal with these increasingly complex problems," ...

Where did you get those eyes and that brain?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: